Novartis takes aim at Shire and Allergan with dry-eye drug
Swiss company takes option on Lubris’ ECF843.
X
Novartis takes aim at Shire and Allergan with dry-eye drug
https://pharmaphorum.com/news/novartis-takes-aim-shire-allergan-dry-eye-drug/
dry eye
Shire launches potential blockbuster dry eye drug in US
Xiidra could be ophthalmology blockbuster.